Designing and developing a new medicine is an expensive, failure-prone scientific challenge. A new drug can take many years to develop, at the cost of a significant investment. And even then, most possible candidates never reach the patient. For biologic medicines, therapies made from engineered…
Thank you for reading this post, don't forget to subscribe!
Source: MIT Technology Review
Automatically aggregated summary — full article and all rights belong to the original publisher.